Browse the corpus

Alpha-blockers are medications used to manage essential hypertension, benign prostatic hyperplasia, and pheochromocytoma. These drugs work by modulating the sympathetic nervous system via alpha-adrenergic receptors, which influence vascular tone and norepinephrine release. Alpha-blockers fall into 3 categories—nonselective alpha-blockers and selective alpha-1 and alpha-2 blockers. Nonselective alpha-blockers may cause adverse effects such as hypotension, weakness, tachycardia, and tremulousness. Selective alpha-1 blockers are less likely to produce systemic effects such as tachycardia and tremulousness but are associated with adverse effects, including first-dose hypotension, syncope, dizziness, and headache due to their vasodilatory action and relaxation of vascular smooth muscle. This activity reviews the indications, contraindications, mechanisms of action, adverse events, and other key elements of alpha-blocker therapy in the clinical setting. This activity also focuses on the essential criteria for interprofessional healthcare team members to collaborate and treat patients with these conditions. Objectives: Identify the appropriate indications for alpha-blocker use, including hypertension, benign prostatic hyperplasia, and pheochromocytoma. Assess the risk of adverse effects, such as orthostatic hypotension, tachycardia, and syncope, especially in patients starting alpha-blocker therapy. Apply evidence-based guidelines to monitor and manage patients on alpha-blockers, adjusting treatment as needed for efficacy and safety. Collaborate with interprofessional healthcare providers, including physicians, pharmacists, and nurses, to optimize patient care and minimize the risk of adverse outcomes related to alpha-blocker therapy. Access free multiple choice questions on this topic.

Alpha-blockers are frequently prescribed to older male populations, and toxicity is common in these individuals. The most common adverse effect is hypotension, which, when severe, can cause ischemic damage to major organs and increase the risk of falls. Alpha-blockers may increase the risk of significant hypotension when used in combination with 5-aminolevulinic acid in bladder cancer patients undergoing photodynamic-enhanced cystoscopic diagnosis.[35] General measures should be taken to optimize blood pressure if toxicity is suspected.[36] If the patient is hypotensive, they should be positioned supine until blood pressure and heart rate stabilize. If hypotension persists, fluid resuscitation may be required. Vasopressors can be administered as a last resort if necessary.[37] No specific antidote is available.

Preventing medication-related adverse effects in older populations requires careful coordination and communication among physicians, pharmacists, and nurses. Selective alpha-1 antagonists are commonly prescribed for patients with BPH in outpatient settings. These medications can interact significantly with other drugs that share similar adverse effects. Clinical staff must thoroughly review the patient's medical and social history before prescribing or ordering an alpha-blocker. In particular, prescribers should be aware that tamsulosin 0.4 mg represents only half of the full recommended dose of 0.8 mg and should consider adjusting the dosage before concluding it is a therapeutic failure. If a patient taking an alpha-blocker resides in a nursing facility, close communication with the nursing staff is essential, as the patient is at an increased risk of orthostatic hypotension, which can lead to falls. Fall precautions, such as bed rails, a bed alarm, a bedside commode, nightlights, and a floor protection mat, should be considered. The administration of alpha-blockers requires collaboration among an interprofessional healthcare team, including physicians, pharmacists, and nurses, to prevent adverse effects, particularly in the older population.